18% Revenue growth and strong operating leverage exceeds consensus expectations for the third quarter of fiscal 2026
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release...
Strong operational execution results in thirteenth consecutive quarter of year-over-year revenue and net income growth
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release...
New Prague, Minnesota--(Newsfile Corp. - November 20, 2025) - Electromed, Inc. (NYSE American: ELMD) ("Electromed" or the "Company"), a leader in innovative airway clearance technologies, today announced...
Strong operational execution results in twelfth consecutive quarter of year-over-year revenue and net income growth
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release...
In a report released today, Kyle Bauser from Roth MKM reiterated a Buy rating on Electromed, with a price target of $35.00. The company’s shares closed last Friday at $24.10.Elevate Your Investing Strategy:...
Management will present Monday, October 20, 2025 at 10:00 am PTNew Prague, Minnesota--(Newsfile Corp. - October 13, 2025) - Electromed, Inc. (NYSE American: ELMD) ("Electromed" or the "Company"), a leader...
Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that on September 9, 2025, its Board of Directors authorized Electromed...